✦ LIBER ✦

Phase II Evaluation of Oral Trimetrexate in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

✍ Scribed by Jeffrey M. Fowler; John A. Blessing; Robert A. Burger; John H. Malfetano

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; Rosenshein, Neil; Photopulos, Guy; DiSaia 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Phase II Trial of Hydroxyurea, Dacarbazi

✍ John L. Currie; John A. Blessing; Ramon McGehee; John T. Soper; Michael Berman 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase II evaluation of topotecan in carc

✍ David Scott Miller; John A. Blessing; Jeanne Schilder; Adnan Munkarah; Yi Chun L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Trimetrexate in the Treatment of Recurre

✍ Harriet O. Smith; John A. Blessing; Luis Vaccarello 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Adjuvant ifosfamide and cisplatin in pat

✍ Gregory Sutton; James Kauderer; Linda F. Carson; Samuel S. Lentz; Charles W. Whi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase II Trial of Paclitaxel in Leiomyos

✍ Gregory Sutton; John A. Blessing; Harrison Ball 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 37 KB